Abstract
Prostate cancer is the most frequent malignancy in elderly men. Common presentations include asymptomatic prostate nodules, unexplained bone pain or bladder outlet obstruction. Histologic grading clearly influences the prognosis. Either potency-saving subcapsular prostatectomy or radiation therapy is effective in treating localized disease. New prospects for hormonal therapy of metastatic prostate cancer include antiandrogens and gonadotropin-releasing analogs.
MeSH terms
-
Age Factors
-
Aged
-
Androgen Antagonists / therapeutic use
-
Antineoplastic Agents / therapeutic use
-
Bone Diseases / etiology
-
Estrogens / therapeutic use
-
Humans
-
Male
-
Middle Aged
-
Neoplasm Metastasis
-
Pain / etiology
-
Pituitary Hormone-Releasing Hormones / therapeutic use
-
Prostate / pathology
-
Prostatectomy
-
Prostatic Neoplasms / diagnosis
-
Prostatic Neoplasms / radiotherapy
-
Prostatic Neoplasms / therapy*
-
Radiotherapy Dosage
-
Urinary Bladder Neck Obstruction / etiology
Substances
-
Androgen Antagonists
-
Antineoplastic Agents
-
Estrogens
-
Pituitary Hormone-Releasing Hormones